JBM Healthcare Announces Updated Board and Committee Structure Effective 10 August 2026

Bulletin Express08-10

JBM (Healthcare) Limited released an updated list of directors and their respective roles, confirming the composition of its Board and four key committees—Audit, Remuneration, Nomination and Executive—effective 10 August 2026.

Board leadership • Mr. Derek Sum Kwong Yip continues as Chairman of the Board, Chief Executive Officer and Executive Director, and serves as Chairman of the Executive Committee.

Executive Directors • Mr. Yim Chun Leung and Dr. Cheng Celine Heung Kwan remain on the Board and are members of the Executive Committee.

Non-executive Director • Mr. Yeung Kwok Chun, Harry holds the position of Non-executive Director.

Independent Non-executive Directors and committee responsibilities • Mr. Chan Kam Chiu, Simon – Member, Audit Committee. • Mr. Luk Ting Lung, Alan – Chairman of the Audit, Remuneration and Nomination Committees. • Mr. Lau Shut Lee, Tony – Member of the Audit, Remuneration and Nomination Committees.

The announcement clarifies governance duties across all committees, reinforcing JBM Healthcare’s board oversight and corporate governance framework as of the stated effective date.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment